Panoramic: Automotive and Mobility 2025
Emerging Companies and Investors - Life Sciences and Health Care
We don't just get you off the ground; we're here to grow with you.
- Menu
We don't just get you off the ground; we're here to grow with you.
From corporate formation to patent protection and strategy to initial financing rounds, we help your company lay a strong foundation, with life sciences and health care industry expertise at the forefront throughout. As your business grows and your needs evolve, so does our team of lawyers who can support your company’s strategic business needs relative to your product’s development stage, including regulatory approval planning, clinical trial design, pricing and reimbursement strategy, licensing, collaborations and other commercial transactions, and commercialization and product launch planning. And when the time comes, we’re prepared to support you in exit planning and execution through IPO, mergers and acquisitions, or asset monetization through strategic collaborations and cross-border licensing.
Read more about our capabilities
Benefits of our accelerator program include:
- Special pricing package to accommodate your business strategy and needs.
- Dedicated support from a team that works seamlessly together to help you accomplish your business goals.
For more information, please contact us.
Our capabilities at a glance
00
+
Judicial review wins
2
Ex-government policy advisors
00
+
Pieces of legislation changed
Hear from our clients and industry leaders
The whole team is super smart. They are all really easy to work with and then know our business inside out. They come to us proactively with issues and are incredibly responsive.
Chambers & Partners, UK Guide, 2025
An intellectually brilliant and commercially astute public law team. One of the very best in the city.
Chambers & Partners UK 2025
Hogan Lovells has a high capability in solving complex issues that involve both legal and technical perspectives.
Chambers & Partners, Germany, 2025
The lawyers are just experts. They are there when you need them and happy to entertain all my questions. They understand the wider context and the politics and sensitivities of it.
Chambers & Partners, UK 2025
Representative experience
Morphosys on a worldwide collaboration and license agreement with Incyte Corporation to co-commercialize tafasitamab for the treatment of B cell malignancies.
Pacira Pharmaceuticals on its agreement with DePuy Synthes to jointly market and promote the use of EXPAREL™ for orthopedic procedures in the U.S.
Kite Pharma, on its investment in HifiBio's US$67m Series C financing.
Sensors for Medicine and Science on its US$54.1m Series D financing.
Pyxis Oncology on IP strategy, patent prosecution, and supporting IP diligence for its $168 million IPO and $152 million Series B financing.
Genome Medical on patent prosecution, prior art searches, and patent strategy development.
Tessera Therapeutics on its IP needs including patent prosecution, strategy, and transactional matters.
Medical device start up in obtaining clearance of a 510(k) notice without clinical data for a cardiac bypass device after the FDA required PMA approval.
Heartflow in obtaining Medicare coverage and reimbursement for its new software technology.
Juno Therapeutics on its comprehensive FDA regulatory, reimbursement, and launch planning for its CAR-T therapies under development.
Lead digital health companies on data privacy matters with regard to clinical trials in the EU involving both pan-European strategic advice and detailed country-specific guidance.
Emerging biotech companies on data questions related to structuring clinical trials, informed consents, patient support programs, and specialty pharmacy arrangements.
Navigate change with our latest insights
You may also be interested in...
Press releases
Hogan Lovells advises OncoResponse on closing of $50m senior secured loan
18 February 2022
Press releases
Hogan Lovells advises OncoResponse on closing of $50m senior secured loan
18 February 2022
Press releases
Hogan Lovells advises Avidea Technologies on acquisition by Vaccitech
21 December 2021
Press releases
Hogan Lovells advises OncoResponse on closing of $50m senior secured loan
18 February 2022
Press releases
Hogan Lovells advises OncoResponse on closing of $50m senior secured loan
18 February 2022
Press releases
Hogan Lovells advises Avidea Technologies on acquisition by Vaccitech
21 December 2021